A weekly injection. Semaglutide is a GLP-1 receptor agonist that decreases blood sugar and suppresses appetite, leading to up to 20% weight loss in clinical studies.

A daily oral tablet. Semaglutide is a GLP-1 receptor agonist that decreases blood sugar and suppresses appetite, leading to up to 20% weight loss in clinical studies.

A weekly injection. Tirzepatide works by targeting both GLP-1 and GIP receptors, resulting in more effective blood sugar control and weight loss, with patients losing an average of 12 pounds more than those on Semaglutide.

A daily oral tablet. Tirzepatide works by targeting both GLP-1 and GIP receptors, resulting in more effective blood sugar control and weight loss, with patients losing an average of 12 pounds more than those on Semaglutide.

Specially tailored weight loss supplement programs designed to support your unique goals, based on your healthcare provider’s recommendations for what will benefit you most. *Cost can vary depending on which supplements are chosen. $60/month when paid upfront in full.